Skip to main content
AVAH logo

AVAH · Aveanna Healthcare Holdings, Inc. · Documents

Track AVAH — free
$11.50 -0.74 (-6.05%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Market Cap
$2.51B
Shares
218.41M
Volume · Nov 13 4.27M Avg daily vol (3M) 3.01M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $2.43B up 20.2% 10-K filed Mar 19, 2026 Quarterly report New FY2026 Q3 Revenue $695.54M up 11.8% 10-Q filed Nov 12, 2026 Latest results New Financial results 8-K filed Nov 12, 2026 Earnings call Q2 2026 earnings call Held Aug 13, 2026
2026
Nov 13
Current report 8-K
Q3 revenue rises 11.8%; Adjusted EBITDA reaches $100.1 million

Aveanna Healthcare Holdings Inc. reported Q3 2026 revenue of $695.5 million, up 11.8%, gross margin of 32.6% and Adjusted EBITDA of $100.1 million. YTD free cash flow reached $141.2 million, and liquidity totaled $492.1 million.

Regulation FD disclosure
3 source passages
Q3 2026 Financial Performance: Summary Results Free Cash Flow of positive $141.2m for 2026, a $55.0m improvement compared to 2025 $ in millions Q3 2025 Q3 2026 Y/Y% Change Revenue $621.9 $695.5 11.8% Gross Margin $202.8 $226.8 11.8% Adjusted EBITDA(1) $80.1 $100.1 25.0% 32.6% 32.6% 29.0% 28.9% 53.3% 53.3% 45.0% 45.2% Gross Margin % Liquidity of $492.1m, comprised of the following: Open the document at this passage
Nov 12
Quarterly report 10-Q FY2026 Q3, ended Oct 3
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $695.54M ▲ 11.8% Net income $45.45M ▲ 223.2% Diluted EPS $0.20 ▲ 233.3%
Oct 2
Current report 8-K Events of Oct 1
Director or officer change, or executive pay

On October 1, 2026, Steven E. Rodgers resigned effective immediately from Aveanna Healthcare Holdings Inc.’s Board of Directors, citing no disagreement with the company over its operations, policies, or practices; he served on the Audit and Compensation Committees.

Aug 24
Current report 8-K
Other events AI summary on its way
Aug 13
Quarterly report 10-Q FY2026 Q2, ended Jul 4
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $670.48M ▲ 13.7% Net income $40.29M ▲ 49.1% Diluted EPS $0.18 ▲ 38.5%
Jun 2
Current report 8-K Events of Jun 1
Other events AI summary on its way
May 28
Current report 8-K Events of May 26
Other events AI summary on its way
May 14
Quarterly report 10-Q FY2026 Q1, ended Apr 4
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $647.92M ▲ 15.9% Net income $41.65M ▲ 702.1% Diluted EPS $0.19 ▲ 533.3%
Apr 17
Proxy statement DEF 14A Meeting May 29, 2026
Proxy statement AI summary on its way
Mar 19
Annual report 10-K FY2025, ended Jan 3
Annual report for FY2025 AI summary on its way
Revenue $2.43B ▲ 20.2% Net income $225.03M Diluted EPS $1.05
Mar 12
Current report 8-K Events of Mar 9
Other events AI summary on its way
2025
Aug 7
Quarterly report 10-Q FY2025 Q2, ended Jun 28
Quarterly report for FY2025 Q2
Revenue $589.55M ▲ 16.8% Net income $27.03M ▲ 94.3% Diluted EPS $0.13 ▲ 85.7%
Showing 1–50 of 151 documents
Key facts CIK 1832332 CUSIP 05356F105 13F (30d) 187 filings 172 filers Visit website Investor relations